In fact, a recent study has revealed that IL-4 gene therapy in our mouse model delays the onset of ALS and ameliorates clinical outcomes during the early slowly progressive phase of the disease [51]. This evidence concerns the gene IL4 and amyotrophic lateral sclerosis.